Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Califf Responds To, And Deflects, Senators’ Mifepristone Questions

Apr 19 2023

• By Derrick Gingery

Califf at Senate Appropriations subcommittee hearing — FDA Commissioner Robert Califf answers questions during a Senate Approrpriations subcommittee hearing on the agency's FY 2024 budget request. • Source: Screenshot of Senate Broadcast

Related Content

The Same But Different: Biden Budget Proposes Flexibility For Generic Drug-Device Combos, ‘Skinny Labels’

Mar 10 2023

PhRMA Jumps Into Battle Over Mifepristone Regulation With Supreme Court Filing

Apr 15 2023

FDA's Woodcock To Supreme Court: Mifepristone Ruling Will Create 'Significant Chaos’

Apr 15 2023

Fifth Circuit Mifepristone Ruling May Temporarily Halt Pharmacy Dispensing, Generic Approval

Apr 13 2023

Additional Topics

United States Legal Issues Women's Health Politics Regulation Drug Review Drug Safety Gynecology & Urology BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.